U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524335) titled 'Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial' on April 05.
Brief Summary: In patients with subclinical coronary artery disease, the ASCAD-P study aims to assess the feasibility of a larger phase 3 pragmatic randomized controlled trial comparing prescription versus no prescription of low-dose aspirin in routine clinical practice.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Coronary Artery Disease
Subclinical Atherosclerotic Cardiovascular Disease
Intervention:
DRUG: Prescription of Aspirin
Aspirin 81 mg orally once daily
DRUG: No prescription
No prescription of aspir...